159 related articles for article (PubMed ID: 33780150)
1. Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
Kreutzer J; Armstrong AK; Rome JJ; Zellers TM; Balzer DT; Zampi JD; Cabalka AK; Javois AJ; Turner DR; Gray RG; Moore JW; Weng S; Jones TK; Khan DM; Vincent JA; Hellenbrand WE; Cheatham JP; Bergersen LJ; McElhinney DB
Catheter Cardiovasc Interv; 2021 Aug; 98(2):E262-E274. PubMed ID: 33780150
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve.
Shahanavaz S; Berger F; Jones TK; Kreutzer J; Vincent JA; Eicken A; Bergersen L; Rome JJ; Zahn E; Søndergaard L; Cheatham JP; Weng S; Balzer D; McElhinney D
JACC Cardiovasc Interv; 2020 Jul; 13(13):1529-1540. PubMed ID: 32646693
[TBL] [Abstract][Full Text] [Related]
3. Endocarditis After Transcatheter Pulmonary Valve Replacement.
McElhinney DB; Sondergaard L; Armstrong AK; Bergersen L; Padera RF; Balzer DT; Lung TH; Berger F; Zahn EM; Gray RG; Hellenbrand WE; Kreutzer J; Eicken A; Jones TK; Ewert P
J Am Coll Cardiol; 2018 Dec; 72(22):2717-2728. PubMed ID: 30497557
[TBL] [Abstract][Full Text] [Related]
4. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.
Armstrong AK; Balzer DT; Cabalka AK; Gray RG; Javois AJ; Moore JW; Rome JJ; Turner DR; Zellers TM; Kreutzer J
JACC Cardiovasc Interv; 2014 Nov; 7(11):1254-62. PubMed ID: 25459038
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial.
Cheatham JP; Hellenbrand WE; Zahn EM; Jones TK; Berman DP; Vincent JA; McElhinney DB
Circulation; 2015 Jun; 131(22):1960-70. PubMed ID: 25944758
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.
Jones TK; McElhinney DB; Vincent JA; Hellenbrand WE; Cheatham JP; Berman DP; Zahn EM; Khan DM; Rhodes JF; Weng S; Bergersen LJ
Circ Cardiovasc Interv; 2022 Jan; 15(1):e010852. PubMed ID: 34930015
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.
Cabalka AK; Asnes JD; Balzer DT; Cheatham JP; Gillespie MJ; Jones TK; Justino H; Kim DW; Lung TH; Turner DR; McElhinney DB
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1712-1724.e1. PubMed ID: 29395214
[TBL] [Abstract][Full Text] [Related]
8. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial.
McElhinney DB; Cheatham JP; Jones TK; Lock JE; Vincent JA; Zahn EM; Hellenbrand WE
Circ Cardiovasc Interv; 2011 Dec; 4(6):602-14. PubMed ID: 22075927
[TBL] [Abstract][Full Text] [Related]
9. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies.
McElhinney DB; Benson LN; Eicken A; Kreutzer J; Padera RF; Zahn EM
Circ Cardiovasc Interv; 2013 Jun; 6(3):292-300. PubMed ID: 23735475
[TBL] [Abstract][Full Text] [Related]
10. Leaflet morphology classification of the Melody Transcatheter Pulmonary Valve.
Boe BA; Cheatham SL; Armstrong AK; Berman DP; Chisolm JL; Cheatham JP
Congenit Heart Dis; 2019 Mar; 14(2):297-304. PubMed ID: 30548926
[TBL] [Abstract][Full Text] [Related]
11. Relationships Among Conduit Type, Pre-Stenting, and Outcomes in Patients Undergoing Transcatheter Pulmonary Valve Replacement in the Prospective North American and European Melody Valve Trials.
Cabalka AK; Hellenbrand WE; Eicken A; Kreutzer J; Gray RG; Bergersen L; Berger F; Armstrong AK; Cheatham JP; Zahn EM; McElhinney DB
JACC Cardiovasc Interv; 2017 Sep; 10(17):1746-1759. PubMed ID: 28823778
[TBL] [Abstract][Full Text] [Related]
12. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials.
Armstrong AK; Berger F; Jones TK; Moore JW; Benson LN; Cheatham JP; Turner DR; Rhodes JF; Vincent JA; Zellers T; Lung TH; Eicken A; McElhinney DB
Catheter Cardiovasc Interv; 2019 Oct; 94(4):607-617. PubMed ID: 31419019
[TBL] [Abstract][Full Text] [Related]
13. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.
Benson LN; Gillespie MJ; Bergersen L; Cheatham SL; Hor KN; Horlick EM; Weng S; McHenry BT; Osten MD; Powell AJ; Cheatham JP
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008320. PubMed ID: 32525412
[TBL] [Abstract][Full Text] [Related]
14. Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve.
Bergersen L; Benson LN; Gillespie MJ; Cheatham SL; Crean AM; Hor KN; Horlick EM; Lung TH; McHenry BT; Osten MD; Powell AJ; Cheatham JP
JACC Cardiovasc Interv; 2017 Sep; 10(17):1763-1773. PubMed ID: 28882284
[TBL] [Abstract][Full Text] [Related]
15. Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
Morray BH; Jones TK; Coe JY; Gitter R; Martinez JZ; Turner DR; Gray RG; Lung TH; Berman DP; Levi DS
Catheter Cardiovasc Interv; 2019 Feb; 93(3):474-480. PubMed ID: 30419603
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits.
Shahanavaz S; Qureshi AM; Levi DS; Boudjemline Y; Peng LF; Martin MH; Bauser-Heaton H; Keeshan B; Asnes JD; Jones TK; Justino H; Aboulhosn JA; Gray RG; Nguyen H; Balzer DT; McElhinney DB
JACC Cardiovasc Interv; 2018 Mar; 11(6):554-564. PubMed ID: 29566801
[TBL] [Abstract][Full Text] [Related]
17. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.
Markham R; Challa A; Kyranis S; Nicolae M; Murdoch D; Savage M; Malpas T; Radford DJ; Hamilton-Craig C; Walters DL
Heart Lung Circ; 2017 Oct; 26(10):1085-1093. PubMed ID: 28185817
[TBL] [Abstract][Full Text] [Related]
18. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.
Kenny D; Rhodes JF; Fleming GA; Kar S; Zahn EM; Vincent J; Shirali GS; Gorelick J; Fogel MA; Fahey JT; Kim DW; Babaliaros VC; Armstrong AK; Hijazi ZM
JACC Cardiovasc Interv; 2018 Oct; 11(19):1920-1929. PubMed ID: 30286853
[TBL] [Abstract][Full Text] [Related]
19. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts.
Meadows JJ; Moore PM; Berman DP; Cheatham JP; Cheatham SL; Porras D; Gillespie MJ; Rome JJ; Zahn EM; McElhinney DB
Circ Cardiovasc Interv; 2014 Jun; 7(3):374-80. PubMed ID: 24867892
[TBL] [Abstract][Full Text] [Related]
20. Experience and Outcomes of Surgically Implanted Melody Valve in the Pulmonary Position.
Feins EN; Chávez M; Callahan R; Del Nido PJ; Emani SM; Baird CW
Ann Thorac Surg; 2021 Mar; 111(3):966-972. PubMed ID: 32603706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
